Schultze Special Purpose Acquisition in a preliminary proxy set a shareolder meeting for Dec. 17 to vote on the proposed combination with Clever Leaves Holdings. The deal would give the combined company an exterprise value of approximately $206 million. Read more.
Related Posts
Brookline Capital Prices $50M IPO
Brookline is targeting life science companies in the United States and Europe.
Intrinsic Medicine and Phoenix Biotech Acquisition to Combine
Assuming no redemptions of the SPAC's shares, Intrinsic would receive up to $178.8 million of cash held in trust. The business combination reflects a pre-money equity value of $136 million for Intrinsic.
Peridot Shareholders Approve $1.7B Li-Cycle Deal
Approximately 11% of Peridot shares were redeemed, the SPAC said in a news release.
Verdant Earth Technologies Reportedly in SPAC Discussions for $161M Deal
Alteration Earth announced that it signed a non-binding agreement to acquire Verdant in an all-stock transaction.